Medicine
-
Ela Knapik: What Fish Can Reveal About Disease
Ela Knapik still remembers the first zebrafish she saw under a microscope—two days old, no bigger than an eyelash, tail wiggling, heart visibly beating. That was more than 20 years ago during her search for a postdoc position. That tiny fish has held her attention ever since and helped unravel many of the biological mysteries she has published about during her professional career. Read MoreAugust 12, 2026
-
Quantum Potential video: The Faith-Fueled Brain Scanner
Meet Audrey Bowden Audrey Bowden Associate professor of biomedical engineering and electrical engineering and Dorothy J. Wingfield Phillips Chancellor’s Faculty Fellow Raised in Nashville, Audrey is a biomedical engineer working in biomedical optics, microfluidics and point-of-care diagnostics. She is focused on development and deployment of low-cost, high-performing technologies for… Read MoreJanuary 7, 2025
-
Quantum Potential Video: Vaccine Visionary
Meet Dr. James Crowe Dr. James Crowe Director of the Vanderbilt Vaccine Center, Ann Scott Carell Chair and professor of pediatrics and pathology, microbiology and immunology Physician scientist Dr. James Crowe has a broad research portfolio including viral immunology and antibody sciences. His goal is discovering mechanisms… Read MoreDecember 23, 2024
-
Research snapshot: Examining the impact of negative media coverage on LGBTQ+ young adults
Kirsty Clark, assistant professor of medicine, health, and society, studies mental health disparities impacting LGBTQ+ populations through her lab. Clark recently published research that explores the effects of negative news and media coverage on the intensity of suicidal thoughts in LGBTQ+ young adults. Read MoreSeptember 19, 2024
-
Vanderbilt biochemists contribute to breakthrough discovery of first new antibacterial class in decades
Led by Neil Osheroff, Vanderbilt researchers are the first to undertake a systematic analysis of the mechanism of action of gepotidacin, a first-in-class triazaacenaphthylene antibacterial, against its targets in Escherichia coli—the type II topoisomerases gyrase and topoisomerase IV—and the mechanistic basis for drug resistance. E. coli is the etiological agent of most urinary tract infections. Read MoreMarch 28, 2024
-
Sanders promoted to vice dean of Basic Sciences
Chuck Sanders, Aileen M. Lange and Annie Mary Lyle Chair of Cardiovascular Research and professor of biochemistry and medicine, has recently been promoted from associate dean for research to vice dean of the Vanderbilt School of Medicine Basic Sciences. Read MoreMarch 9, 2023
-
Vanderbilt University, VUMC faculty named Highly Cited Researchers, rank in top 1 percent by citations
Experts from the Institute for Scientific Information identified 13 faculty at Vanderbilt University and Vanderbilt University Medical Center as among the top one percent of cited researchers worldwide. Read MoreDecember 6, 2022
-
Meet the alpacas that are helping researchers who study autism, Alzheimer’s and cancer
Written by Heidi Hall Alpacas aren’t the typical animals that drivers spot as they wind their way through rural Tennessee, but there’s a happy herd of them outside Waverly, where they eat the finest pellets, walk up and down a scenic hill and potentially save lives. They’re owned by… Read MoreAugust 13, 2019
-
Men’s health issues In Tennessee vary widely based on race, ethnicity and geographic region; 2014 Report Card shows progress
White men are more apt to commit suicide or die from a drug overdose or in a car wreck. Black men are more prone to suffer from chronic diseases and HIV. Hispanic men are disproportionately affected by colorectal cancer. Men in rural and urban areas seem to face different health challenges too. Read MoreJune 10, 2014
-
Two Vanderbilt projects featured in new NIBIB “Bionic Man” web tool
The prosthetics research of Michael Goldfarb is featured in "The NBIB Bionic Man," an interactive web tool that helps students and the public learn about innovative federally-funded biomedical research. Read MoreMay 6, 2014